The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of 1-year adjuvant chemotherapy with oral tegafur-uracil (UFT) vs. surgery alone in stage II colon cancer: SACURA trial.
 
Yoshiki Kajiwara
No Relationships to Disclose
 
Megumi Ishiguro
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Honsha
 
Satoshi Teramukai
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Sanofi; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Chu Matsuda
No Relationships to Disclose
 
Shoichi Fujii
No Relationships to Disclose
 
Yusuke Kinugasa
No Relationships to Disclose
 
Yoshihiko Nakamoto
No Relationships to Disclose
 
Masanori Kotake
No Relationships to Disclose
 
Yoshiyuki Sakamoto
No Relationships to Disclose
 
Kiyotaka Kurachi
No Relationships to Disclose
 
Atsuyuki Maeda
No Relationships to Disclose
 
Koji Komori
No Relationships to Disclose
 
Naohiro Tomita
Research Funding - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Yasuhiro Shimada
Honoraria - Chugai Pharma; Lilly; Taiho Pharmaceutical; Takeda
Research Funding - Lilly; Merck Serono; Taiho Pharmaceutical
 
Keiichi Takahashi
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Kenjiro Kotake
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Masahiko Watanabe
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Hidetaka Mochizuki
Consulting or Advisory Role - Otsuka
 
Kenichi Sugihara
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Taiho Pharmaceutical